Acadia Healthcare Company, Inc. Stock

$21.90

0.70% yesterday

Nasdaq, Jun 27, 10:13 pm CET

ISIN

US00404A1097

Symbol

ACHC

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

Acadia Healthcare Company, Inc. Stock price

$21.90

-3.02 12.12% 5Y

Nasdaq, Closing price Fri, Jun 27 2025

-0.16 0.70%

ISIN

US00404A1097

Symbol

ACHC

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Health

Industry

Health service provider

Key metrics

Basic

Market capitalization

$2.0b

Enterprise Value

$4.1b

Net debt

$2.1b

Cash

$91.2m

Shares outstanding

90.4m

Valuation (TTM | estimate)

P/E

10.74 | 8.17

P/S

0.64 | 0.59

EV/Sales

1.31 | 1.21

EV/FCF

negative

P/B

0.65

Financial Health

Equity Ratio

51.60%

Return on Equity

8.32%

ROCE

8.32%

ROIC

6.14%

Debt/Equity

0.72

Financials (TTM | estimate)

Revenue

$3.2b | $3.4b

EBITDA

$632.2m | $698.6m

EBIT

$471.9m

Net Income

$187.6m | $242.4m

Free Cash Flow

$-260.2m

Growth (TTM | estimate)

Revenue

5.48% | 7.83%

EBITDA

-4.29% | 3.97%

EBIT

-9.84%

Net Income

1,761.65% | -5.17%

Free Cash Flow

35.51%

Margin (TTM | estimate)

Gross

EBITDA

20.03% | 20.54%

EBIT

14.95%

Net

5.94% | 7.13%

Free Cash Flow

-8.24%

EPS

$2.04

FCF per Share

$-2.88

Short interest

11.74%

Employees

22.35k

Rev per Employee

$140.00k

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Get Started for Free Today

Acadia Healthcare Company, Inc. Stock Analysis

Unlock Scores for Free

??

20 Analysts have issued a Acadia Healthcare Company, Inc. forecast:

15x Buy

75%

5x Hold

25%

More details on Analyst Estimates Including Price Targets

20 Analysts have issued a Acadia Healthcare Company, Inc. forecast:

Buy

75%

Hold

25%

Analyst Estimates with Stock Price Targets

Financial data from Acadia Healthcare Company, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	3,156 3,156	5% 5% 100%
- Direct Costs	- -	- -
Gross Profit	- -	- -
- Selling and Administrative Expenses	2,071 2,071	7% 7% 66%
- Research and Development Expense	- -	- -
EBITDA	632 632	4% 4% 20%
- Depreciation and Amortization	160 160	17% 17% 5%
EBIT (Operating Income) EBIT	472 472	10% 10% 15%
Net Profit	188 188	1,762% 1,762% 6%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Acadia Healthcare Company, Inc. Stock News

Neutral

Business Wire

●

18 days ago

Acadia Healthcare Investor Alert: Scott+Scott Attorneys at Law LLP Investigates Acadia Healthcare Company, Inc.'s Directors and Officers for Breach of Fiduciary Duties – ACHC

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) breached their fiduciary duties to Acadia Healthcare and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether member...

Neutral

Accesswire

●

19 days ago

INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Acadia Healthcare Company, Inc. and Encourages Long-Term Acadia Investors to Contact the Firm - ACHC

PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia") on behalf of the company's long-term investors. Click here to receive additional information about your legal rights and options: https://kaskelalaw.com/case/acadia-healthcare/ Recentl...

Neutral

Business Wire

●

about one month ago

ACADIA HEALTHCARE INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Acadia Healthcare Company, Inc.'s Directors and Officers for Breach of Fiduciary Duties – ACHC

More Acadia Healthcare Company, Inc. News

Company Profile

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment classified in the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. The U.K. Facilities segment provides inpatient services through facilities, including mental health hospitals, clinics, care homes, schools, colleges, and children's homes. The company was founded in January 2005 and is headquartered in Franklin, TN.

Head office	United States
CEO	Christopher Hunter
Employees	22,346
Founded	2005
Website	www.acadiahealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now